Hepatocellular carcinoma (HCC) is the most common type of liver cancer in Switzerland and worldwide. For eligible patients, liver surgery or hepatectomy is an effective treatment option. However, ...
AZoLifeSciences on MSN
Scientists Reveal How Nanovaccines Boost the Immune Fight Against Aggressive Breast Cancers
Nanovaccines show promise in breast cancer therapy, enhancing immune activation and targeting cold tumors, particularly in ...
News-Medical.Net on MSN
Mitochondria and lysosomes work together to control regulatory T cell activation
Metabolism guides the activation states of regulatory T cells, the immune cells that prevent inappropriate activation of the ...
News Medical on MSN
Leveraging the power of T cells for more effective and durable cancer immunotherapies
T cells play central roles in the adaptive immune response against cancer. Their functional inactivation is a primary driver of tumor progression, making the reactivation of T cell function a main ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results